PVP Ventures Limited
Incorporated in 1991, PVP VenturesLtd develops urban infrastructureand investments in various ventures
What PVP files
- Others70
- Important27
- Board Meeting21
- Updates12
- Dividend/Bonus3
- Insider Trade2
PVP Ventures announces its 35th Annual General Meeting online. The FY26 Annual Report is available via weblink. Shareholders, especially those with physical shares, are urged to update contact and KYC details for seamless electronic payments and communications.
PVP Ventures is pivoting to an integrated healthcare platform (Cancer, Renal, Senior, Women's Health), proposing a name change to Evervie Health. Acquisitions in diagnostics & oncology boosted consolidated revenue to 89.71 Cr. Raised 150 Cr via NCDs for expansion, but consolidated results showed a loss amid strategic shifts. Facing audit...
Company approved Q1 financial results with standalone net profit soaring to ₹15.11 Cr and consolidated to ₹11.06 Cr. It boosted its stake in 7Med India to 41.23% for ₹19.26 Cr. Two directors resigned; Dr. Ellen Jane Feehan is now Executive Director & CEO. An ₹10.85 Cr impairment loss was noted...
PVP Ventures fixed July 20, 2026, as Record Date for NCD interest payments. Eligible debenture holders will receive interest on July 21, 2026. A routine interest payout for NCD investors.
PVP Ventures extended principal repayment for its Rs 95 Cr and Rs 55 Cr Non-Convertible Debentures. Originally due by June 2026, repayments are now deferred to begin June 2027, with the full schedule running until March 2029, enhancing the company's financial flexibility.